共 219 条
- [71] Raza Q(2021)Fluoxetine can inhibit SARS-CoV-2 in vitro Sci Rep 178 undefined-undefined
- [72] Dinakaran D(2021)The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue Br J Pharmacol 10 undefined-undefined
- [73] Manjunatha N(2022)Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection Lancet Glob Health 14 undefined-undefined
- [74] Naveen Kumar C(2019)Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial Expert Opin Drug Discov 75 undefined-undefined
- [75] Cao W(2020)Vortioxetine: a novel antidepressant for the treatment of major depressive disorder J Antimicrob Chemother 16 undefined-undefined
- [76] Fang Z(2020)Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19 Ther Clin Risk Manag 12 undefined-undefined
- [77] Hou G(2021)The current recommended drugs and strategies for the treatment of coronavirus disease (COVID-19) Front Pharmacol undefined undefined-undefined
- [78] Ozdin S(undefined)The anti-inflammatory effect of the tricyclic antidepressant clomipramine and its high penetration in the brain might be useful to prevent the psychiatric consequences of SARS-CoV-2 infection undefined undefined undefined-undefined
- [79] Bayrak OS(undefined)undefined undefined undefined undefined-undefined
- [80] Giamarellos-Bourboulis EJ(undefined)undefined undefined undefined undefined-undefined